| [1] |
Belanger HG,Tracy K,Ruth YG, et al.Cognitive sequelae of blast-related versus other mechanisms of brain trauma[J]. J Int Neuropsychol Soc, 2009, 15(1): 1-8.
|
| [2] |
Mcdonald JA,Ballard M. Primary Blast Lung Injury[J]. Am J Respir Crit Care Med, 2015, 191(12): 1462-1463.
|
| [3] |
Singleton JA,Gibb IE,Bull AM, et al.Primary blast lung injury prevalence and fatal injuries from explosions：insights from postmortem computed tomographic analysis of 121 improvised explosive device fatalities[J]. J Trauma Acute Care Surg, 2013, 75(2 Suppl 2): S269-S274.
|
| [4] |
Cereda M,Xin Y,Meeder N, et al.Visualizing the propagation of acute lung injury[J]. Anesthesiology, 2016, 124(1): 121-131.
|
| [5] |
Knöferl MW,Liener UC,Seitz DH, et al.Cardiopulmonary, histological and inflammatory alterations after lung contusion in a novel mouse model of blunt chest trauma[J]. Shock, 2003, 19(6): 519-525.
|
| [6] |
Nicolas B,Ware LB.Biomarkers in Acute Lung injury-marking forward progress[J]. Critical Care Clinics, 2011, 27(3): 661-683.
|
| [7] |
Fiedler U,Augustin HG.Angiopoietins：a link between angiogenesis and inflammation[J]. Trends Immunol, 2006, 27(12): 552-558.
|
| [8] |
Jones PF.Not just angiogenesis-wider roles for the angiopoietins[J]. J Pathol, 2003, 201(4): 515-527
|
| [9] |
Calfee CS,Gallagher D,Abbott J, et al.Plasma angiopoietin-2 in clinical acute lung injury：prognostic and pathogenetic significance[J]. Crit Care Med, 2012, 40(6): 1731-1737.
|
| [10] |
Fogli S,Mogavero S,Egan CG, et al.Pathophysiology and pharmacological targets of VEGF in diabetic macular edema[J]. Pharmacol Res, 2015(103): 149-157.
|
| [11] |
Prokosch V,Fink J,Heiduschka P, et al.VEGF, Ang-2 and SRIF associated abnormal postnatal development of the retinal capillary network in the royal college of surgeons rat[J]. Exp Eye Res, 2011, 92(2): 128-137.
|
| [12] |
Huang J,Bae JO,Tsai JP, et al.Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade[J]. Int J Oncol, 2009, 34(1): 79-87.
|
| [13] |
Thickett DR,Armstrong L,Christie SJ, et al.Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2001, 164(9): 1601-1605.
|
| [14] |
Abadie Y,Bregeon F,Papazian L, et al.Decreased VEGF concentration in lung tissue and vascular injury during ARDS[J]. Eur Respir J, 2005, 25(1): 139-146.
|
| [15] |
Marianor M,Zaidah AW,Maraina ChC.Von willebrand factor propeptide：A potential disease biomarker not affected by ABO blood groups[J]. Biomark Insights, 2015(10): 75-79.
|
| [16] |
殷杰,阮长耿. 血管性血友病因子前导肽的作用及临床价值[J]. 中华血液学杂志, 2015, 36(10): 883-887.
|
| [17] |
Ware LB,Conner ER,Matthay MA.Von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury[J]. Crit Care Med, 2001, 29(12): 2325-2331.
|
| [18] |
Matthay MA,Zemans RL.The acute respiratory distress syndrome：pathogenesis and treatment[J]. Annu Rev Pathol, 2011, 6(1): 147-163.
|
| [19] |
Vanden steen PE,Deroost K,Deckers J, et al.Pathogenesis of malaria-associated acute respiratory distress syndrome[J]. Trends Parasitol, 2013, 29(7): 346-358.
|
| [20] |
Beileke S,Claassen H,Wagner W, et al.Expression and localization of lung surfactant proteins in Human Testis[J]. PLoS One, 2015, 10(11): e0143058.
|
| [21] |
Wang Y,Voelker DR,Lugogo NL, et al.Surfactant protein A is defective in abrogating inflammation in asthma[J]. Am J Physiol Lung Cell Mol Physiol, 2011, 301(4): L598-606.
|
| [22] |
Park HY,Churg A,Wright JL, et al.Club cell protein 16 and disease progression in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2013, 188(12): 1413-1419.
|
| [23] |
Kropski JA,Fremont RD,Calfee CS, et al.Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury[J]. Chest, 2009, 135(6): 1440-1447.
|
| [24] |
Determann RM,Millo JL,Waddy S, et al.Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia：a retrospective observational study[J]. B Pulm Med, 2009(9): 49.
|
| [25] |
Mc Donald Johnston A,Ballard M. Primary Blast Lung Injury[J]. Am J Respir Crit Care Med, 2015, 191(12): 1462-1463.
|
| [26] |
Cross LJ,Matthay MA.Biomarkers in acute lung injury：insights into the pathogenesis of acute lung injury[J]. Critical Care Clinics, 2011, 27(2)L355-377.
|
| [27] |
Christophe Q,Sylvain MA,Aurélie F, et al.Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 294(2): L334-L343.
|
| [28] |
Yang G,Hamacher J,Gorshkov B, et al.The dual role of TNF in pulmonary edema[J]. J Cardiovasc Dis Res, 2010, 1(1): 29-36.
|
| [29] |
Epanchintsev A,Shyamsunder P,Verma RS, et al.IL-6, IL-8, MMP-2, MMP-9 are overexpressed in fanconi anemia cells through a NF-kappaB/TNF-alpha dependent mechanism[J]. Mol Carcinog, 2015, 54(12): 1686-1699.
|
| [30] |
侯晓彬,易定华,李廷慧, 等. P38丝裂原活化蛋白激酶和核转录因子κBP65在胸部爆炸伤致急性肺损伤中的作用[J]. 中华急诊医学杂志, 2005, 14(1)26-29.
|
| [31] |
Lindsay CD.Novel therapeutic strategies for acute lung injury induced by lung damaging agents：the potential role of growth factors as treatment options[J]. Hum Exp Toxicol, 2011, 30(7): 701-724.
|
| [32] |
González-López A,Albaiceta GM.Repair after acute lung injury：molecular mechanisms and therapeutic opportunities[J]. Critical Care, 2012, 16(2): 1-7.
|
| [33] |
Ware LB,Bastarache JA,Wang L. Coagulation and fibrinolysis in human acute lung injury-new therapeutic targets? [J]. Keio J Med, 2005, 54(3): 142-149.
|
| [34] |
Ashish A,Hanjing Z,Sandra B, et al.Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness：results from two clinical trials[J]. Am J Physiol Lung Cell Mol Physiol, 2012, 303(8): L634-639.
|